Andecaliximab is a recombinant IgG4 monoclonal antibody targeting matrix metalloproteinase 9 (MMP9). Andecaliximab showed antifibrotic effects in a mouse model of idiopathic pulmonary fibrosis. Andecaliximab can be used to study gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF), as well as dengue virus.
Purity:
>95%
CAS Number:
[1518996-49-0]
Target:
MMP|||Virus Protease
* VAT and and shipping costs not included. Errors and price changes excepted